A review of emerging evidence suggests that dysregulation of the endocannabinoid system may contribute to the widespread pain, fatigue, and cognitive difficulties characteristic of fibromyalgia.
Fibromyalgia patients, pain researchers, and clinicians exploring cannabinoid-based approaches to chronic pain conditions.
What the researchers found
The endocannabinoid system plays a central role in pain perception, mood regulation, and inflammation, and variations in endocannabinoid levels and receptor activity in fibromyalgia patients may contribute to clinical symptoms.
Why it matters
Fibromyalgia affects millions and remains poorly understood with limited treatment options. If endocannabinoid system dysfunction is a key driver, it could open pathways for targeted cannabinoid-based therapies.
The numbers in context
No specific numerical outcomes reported; this is a qualitative synthesis of existing literature.
How the study worked
Narrative review analyzing published literature on the endocannabinoid system's involvement in fibromyalgia pathophysiology, with a focus on pain modulation mechanisms.
What this study cannot tell us
Narrative review rather than systematic review, so subject to selection bias. Much of the evidence on ECS dysfunction in fibromyalgia is indirect or from small studies.
How to read the evidence
Narrative review synthesizing mostly preliminary evidence from small studies and indirect observations.
When this study was published
2025 publication.
The bigger picture
The "clinical endocannabinoid deficiency" hypothesis has been proposed as an explanation for fibromyalgia, migraines, and irritable bowel syndrome. This review gathers the evidence supporting that theory for fibromyalgia.
Questions still open
- Can endocannabinoid levels serve as biomarkers for fibromyalgia diagnosis or treatment response?
- Would cannabinoid therapies targeting specific ECS components outperform current fibromyalgia treatments?
Common questions
What is the endocannabinoid deficiency theory?
Does this mean cannabis treats fibromyalgia?
Read the original research
Role of the Endocannabinoid System in Fibromyalgia.
Current issues in molecular biology, 47(4)
Citation
García-Domínguez, Mario. (2025). Role of the Endocannabinoid System in Fibromyalgia.. Current issues in molecular biology, 47(4). https://doi.org/10.3390/cimb47040230
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk